18 Members•4,119 Posts

Pharma & Biotech

Imugene showcases Azer-Cel progress at ASCO - ICYMI

Jun 5, 2026

Jonathan Jackson

Noxopharm CEO discusses Sofra cancer platform

Jun 5, 2026

Kerry Stevenson

AtaiBeckley nears key clinical catalysts, Jefferies stays positive with repeat ‘Buy’ rating

Jun 4, 2026

Emily Jarvie

US bank sees GSK oncology pipeline as major value driver after New York conference

Jun 4, 2026

Ian Lyall

Plus Therapeutics gains CAP accreditation for CNSide CSF assay platform

Jun 4, 2026

Proactive

US commercialisation of FebriDx® to be discussed at Lumos Webinar: Thursday, June 11, at 10:30am AEST

Jun 4, 2026

Jonathan Jackson

Incanthera shares jump 21% after it acquires Swiss skincare brand and appoints new chief executive - UPDATE

Jun 4, 2026

Ian Lyall

Perspective Therapeutics doses first brain tumor patient in expanded radiopharmaceutical trial

Jun 3, 2026

Proactive

UBS says UK stocks are better supported but not broadly so, as earnings lead while sentiment drags

Jun 3, 2026

Ian Lyall

Leading Bank maintains sell on AstraZeneca at 11,500p as ASCO glow fails to resolve key pipeline questions

Jun 3, 2026

Ian Lyall

BSF Enterprise shares fall 31% as tissue engineering firm raises £500,000 at 2p

Jun 3, 2026

Ian Lyall

Small cap Watch: Biotech, gold explorers and consumer brands deliver key updates

Jun 3, 2026

Jonathan Jackson

Percheron presents ASCO data supporting HMBD-002's potential in hard-to-treat breast cancer

Jun 3, 2026

Lisa Uhlman

Medicus Pharma advances SkinJect program with FDA submission targeting Gorlin Syndrome

Jun 3, 2026

Emily Jarvie

Faron Pharma issues shares to bondholders

Jun 3, 2026

Ian Lyall

Oxford Biomedica sets £500m revenue target as capital markets day shores investor confidence

Jun 2, 2026

Ian Lyall

hVIVO win with Decoy Therapeutics signals shift towards broader contract research market, says broker

Jun 2, 2026

Ian Lyall

ASCO 2026: A quiet conference for European pharma, but AstraZeneca and Roche both have work to do

Jun 1, 2026

Ian Lyall

Wegovy pill maintains GLP-1 lead over Lilly rival, but weekly growth slows

Jun 1, 2026

Ian Lyall

Iovance Biotherapeutics pushes cell therapy platform into solid tumor market

Jun 1, 2026

Proactive

Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy